Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lin, Tzu Yu ^a,d   Huang, Wei Jan ^b   Wu, Chia Chan ^a   Lu, Cheng Wei ^a,d   Wang, Su Jane ^c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACACETIN; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; GLUTAMIC ACID; KAINIC ACID; OMEGA CONOTOXIN MVIIC; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DEPOLARIZATION; ENDOPLASMIC RETICULUM; ENZYME RELEASE; EXCITOTOXICITY; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HISTOPATHOLOGY; MALE; MICROGLIA; MITOCHONDRION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SODIUM TRANSPORT; SYNAPTIC MEMBRANE; SYNAPTOSOME;

4-AMINOPYRIDINE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL DEATH; FLAVONES; GLUTAMIC ACID; HIPPOCAMPUS; KAINIC ACID; MALE; MEMBRANE POTENTIALS; MICROGLIA; NERVE ENDINGS; NEURONS; NEUROTOXINS; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; SYNAPTOSOMES;

EID: 84895748748     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088644     Document Type: Article

References (60)

1. Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42: 1-11.
2. Greenamyre JT, Porter RH (1994) Anatomy and physiology of glutamate in the CNS. Neurology 44: S7-S13.
3. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23: 1261-1276.
4. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695. (Pubitemid 23350687)
5. Schinder AF, Olson EC, Spitzer NC, Montal M (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 16: 6125-6133. (Pubitemid 26313988)
6. Choi DW, Rothman SM (1990) The role of glutamate neurotoxicity in hypoxicischemic neuronal death. Annu Rev Neurosci 13: 171-182. (Pubitemid 20100647)
7. Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44: S14-S23.
8. Obrenovitch TP, Urenjak J (1997) Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 51: 39-87. (Pubitemid 27080814)
9. Danysz W, Parsons CG (1998) Glycine and N-methyl-D-asparate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50: 597-664. (Pubitemid 29028813)
10. Ikonomidou C, Turski L (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1: 383-386. (Pubitemid 37159164)
11. Cui HS, Huang LS, Sok DE, Shin J, Kwon BM, et al. (2007) Protective action of honokiol, administered orally, against oxidative stress in brain of mice challenged with NMDA. Phytomedicine 14: 696-700. (Pubitemid 47419299)
12. Ye M, Fu S, Pi R, He F (2009) Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. J Pharm Pharmacol 61: 831-837.
13. Wang L, Zhang X, Liu L, Cui L, Yang R, et al. (2010) Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia. Brain Res 1321:143-151.
14. Wu J, Li Q, Wang X, Yu S, Li L, et al. (2013) Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLOS ONE 8: e59843.
15. Sy HN, Wu SL, Wang WF, Wang SJ (2008) Mechanisms underlying the honokiol inhibition of evoked glutamate release from glutamatergic nerve terminals of the rat cerebral cortex. Synapse 62: 890-901.
16. Lin TY, Lu CW, Wang CC, Wang YC, Wang SJ (2011) Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism. Prog Neuropsychopharmacol Biol Psychiatry 35: 1785-1793.
17. Lin TY, Lu CW, Huang SK, Wang SJ (2013) Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals. J Ethnopharmacol 147: 488-496.
18. Lin TY, Lin YW, Lu CW, Huang SK, Wang SJ (2013) Berberine inhibits the release of glutamate in nerve terminals from rat cerebral cortex. PLOS ONE 8:e67215.
19. Chen HL, Lee HJ, Huang WJ, Chou JF, Fan PC, et al. (2012) Clerodendrum inerme leaf extract alleviates animal behaviors, hyperlocomotion, and prepulse inhibition disruptions, mimicking tourette syndrome and schizophrenia. Evid Based Complement Alternat Med 2012: 1-8.
20. Pan MH, Lai CS, Wang YJ, Ho CT (2006) Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem Pharmacol 72: 1293-1303.
21. Shim HY, Park JH, Paik HD, Nah SY, Kim DS, et al. (2007) Acacetin-induced apoptosis of human breast cancer MCF-7 cells involves caspase cascade, mitochondria-mediated death signaling and SAPK/JNK/2-c-Jun activation. Mol Cell 24: 95-104. (Pubitemid 47554796)
22. Shen KH, Hung SH, Yin LT, Huang CS, Chao CH, et al. (2010) Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway. Mol Cell Biochem 333: 279-291.
23. Kim HG, Ju MS, Ha SK, Lee H, Lee H, et al. (2012) Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Bio Phar Bull 35: 1287-1294.
24. Lipton SA, Rosenberg PA (1994) Excitatory amino acid as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622.
25. Nicholls DG (1989) Release of glutamate, aspartate, and gamma-aminobutyric acid from isolated nerve terminals. J Neurochem 52: 331-341.
26. Ferkany JW, Zaczek R, Coyle JT (1982) Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 298:757-759. (Pubitemid 12041373)
27. Ferkany JW, Coyle JT (1983) Kainic acid selectively stimulates the release of endogenous excitatory acid amino acid. J Pharmacol Exp Ther 225: 399-406. (Pubitemid 13091231)
28. Chittajallu R, Vignes MDev KK, Barnes JM, Collingridge GL, Henley JM (1996) Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379:78-91.
29. Nicholls DG, Sihra TS (1986) Synaptosomes possess an exocytotic pool of glutamate. Nature 321: 772-773. (Pubitemid 16077902)
30. Akerman KE, Scott IG, Heikkila JE, Heinonen E (1987) Ionic dependence of membrane potential and glutamate receptor-linked responses in synaptoneurosomes as measured with a cyanine dye, DiSC2(5). J Neurochem 48: 552-559. (Pubitemid 17005167)
31. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 267: 1983-1989.
32. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
33. Minta A, Tsien RY (1989) Fluorescent indicators for sodium. J Biol Chem 264: 19449-19457.
34. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874: 123-130.
35. Friedman LK, Pellegrini-Giampietro DE, Sperber EF, Bennett MV, Moshe SL, et al. (1994) Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization study. J Neurosci 14:1697-1707.
36. Park HJ, Kin HJ, Park HJ, Ra J, Zheng LT, et al. (2008) Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus. Epilepsia 49: 163-167.
37. Paxino G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edition. San Diego, Academic Press.
38. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Nat Acad Sci USA 90: 9518-9522.
39. Vazquez E, Sanchez-Prieto J (1997) Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur J Neurosci 9: 2009-2018. (Pubitemid 27485234)
40. Millan C, Sanchez-Prieto J (2002) Differential coupling of N and P/Q-type calcium channels to glutamate exocytosis in the rat cerebral cortex. Neurosci Lett 330: 29-32. (Pubitemid 35245762)
41. Berridge MJ (1998) Neuronal calcium signaling. Neuron 21: 13-26.
42. Avignone E, Ulmann L, Levavasseur F, Rassendren F, Audinat E (2008) Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J Neurosci 28: 9133-9144.
43. Kim DH, Yoon BH, Jung WY, Kim JM, Park SJ, et al. (2010) Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology 59: 20-30.
44. Wu L, Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20: 204-212. (Pubitemid 27158049)
45. + channels of mammalian brain. FASEB J 5: 164-170.
46. Li M, West JW, Numann R, Murphy BJ, Scheuer T, et al. (1993) Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science 261: 1439-1442. (Pubitemid 23334263)
47. + channel beta subunits. Ann N Y Acad Sci 868: 344-355.
48. Barrie AP, Nicholls DG, Sanchez-Prieto J, Sihra TS (1991) An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J Neurochem 57: 1398-1404. (Pubitemid 21922768)
49. Nicholls DG (1998) Presynaptic modulation of glutamate release. Prog Brain Res 116: 15-22.
50. Li GR, Wang HB, Qin GW, Jin MW, Tang Q, et al. (2008) Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs. Circulation 117: 2449-2457. (Pubitemid 351670451)
51. Wu HJ, Sun HY, Wu W, Zhang YH, Qin GW, et al. (2013) Properties and molecular determinants of the natural flavone acacetin for blocking hKv4.3 channels. PLOS ONE 8: e57864
52. Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403.
53. Spigolon G, Veronesi C, Bonny C, Vercelli A (2010) c-Jun n-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus. Eur J Neurosci 31:1261-72.
54. Pollard H, Héron A, Moreau J, Ben-Ari Y, Khrestchatisky M (1993) Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience 57: 545-554. (Pubitemid 23350545)
55. Bahn S, Volk B, Widsen W (1994) Kainate receptor gene eexpression in the developing rat brain. J Neurosci 14: 5525-5547. (Pubitemid 24279070)
56. Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, et al. (2005) Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79: 522-534. (Pubitemid 40283352)
57. Ha SK, Moon E, Lee P, Ryu JH, Oh MS, et al. (2012) Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo. Neurochem Res 37: 1560-1567.
58. Choi SH, Aid S, Bosetti F (2009) The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmaco Sci 30: 174-181.
59. Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7: 97-107.
60. Klegeris A, McGeer EG, McGeer PL (2007) Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol 20: 351-357. (Pubitemid 46743120)